ZANONE POMA, BARBARA
ZANONE POMA, BARBARA
DIPARTIMENTO DI SCIENZE CLINICHE "LUIGI SACCO" (attivo dal 01/01/2002 al 27/04/2012)
Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection
2012 D.C. Guergnon J, P. Broet, L. Meyer, S. Westrop, N. Imami, E. Vicenzi, G. Morsica, M. Tinelli, B. Zanone Poma, C. Goujard, V. Potard, F. Gotch, C. Casoli, A. Cossarizza, F. Macciardi, P. Debré, J. Delfraissy, M. Galli, B. Autran, D. Costagliola, G. Poli, I. Theodorou, A. Riva
Effect of Antioxidants on Mitochondrial Function in HIV-1-Related Lipoatrophy : A Pilot Study
2010 L. Milazzo, B. Menzaghi, I. Caramma, M. Nasi, O. Sangaletti, M. Cesari, B. Zanone Poma, A. Cossarizza, S. Antinori, M. Galli
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy
2008 B. Zanone Poma, A. Riva, M. Nasi, P. Cicconi, V. Broggini, A.C. Lepri, D. Mologni, F. Mazzotta, A. D'Arminio Monforte, C. Mussini, A. Cossarizza, M. Galli, Icona Foundation Study Group
Vpr and HIV-1 disease progression : R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients
2006 D. Mologni, P. Citterio, B. Menzaghi, B. Zanone Poma, C. Riva, V. Broggini, A. Sinicco, L. Milazzo, F. Adorni, S. Rusconi, M. Galli, A. Riva
Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin
2006 L. Milazzo, M. Biasin, N. Gatti, L. Piacentini, F. Niero, B. Zanone Poma, M. Galli, M. Moroni, M. Clerici, A. Riva
A point mutation affecting an SP1 binding site in the promoter of ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria
2005 E. Di Pierro, M.D. Cappellini, R. Mazzucchelli, D. Mologni, B. Zanone Poma, A. Riva